Instil Bio, Inc.TILNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-45.9%
5Y CAGR+2.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-45.9%/yr
Annual compound
5Y CAGR
+2.9%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.34M | +88.7% |
| 2024 | $11.84M | -70.1% |
| 2023 | $39.60M | -71.9% |
| 2022 | $141.06M | +31.5% |
| 2021 | $107.25M | +452.9% |
| 2020 | $19.40M | +381.7% |
| 2019 | $4.03M | - |